ASLAN Pharmaceuticals Limited American Depositary Shares

Crude oil prices rose 2%, while shares of Five Below plunged 21% after the company announced a CEO transition and a decrease in comparable sales.

Related tickers: AEHR, SHIM, ASLN, SAVA, FIVE.

SAN MATEO, Calif. and SINGAPORE, June 14, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN” or the “Company”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it plans to change the ratio of the American Depositary Shares (“ADSs”) to its ordinary shares, par value $0.01 per share, from one (1) ADS representing twenty-five (25) ordinary shares to one (1) ADS representing two hundred (200) ordinary shares.

Related tickers: ASLN.